AMANDA LI: Open Payments
NPI 1538878426 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,863 in 72 payments from 21 companies in 2025. Trend: 2023 $773 · 2024 $1,894 · 2025 $1,863
Food & beverage: $1,764Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $442 |
| Sumitomo Pharma America, Inc. | 10 | $177 |
| Astellas Pharma US Inc | 2 | $162 |
| Telix Pharmaceuticals | 5 | $143 |
| UROGEN PHARMA, INC. | 6 | $122 |
| PFIZER INC. | 5 | $96 |
| Merck Sharp & Dohme LLC | 3 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $80 |
| Antares Pharma, Inc. | 5 | $76 |
| ACCORD HEALTHCARE, INC. | 3 | $61 |
Products named: ERLEADA, GEMTESA, ILLUCCIX, Padcev, Xtandi, Nubeqa, XYOSTED, KEYTRUDA.
Industry payments across NV — which companies pay providers there.
